297 related articles for article (PubMed ID: 18990612)
21. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
[TBL] [Abstract][Full Text] [Related]
22. NovaSure impedance controlled endometrial ablation: long-term follow-up results.
Fulop T; Rákóczi I; Barna I
J Minim Invasive Gynecol; 2007; 14(1):85-90. PubMed ID: 17218236
[TBL] [Abstract][Full Text] [Related]
23. Hysterectomy on benign indications in Sweden 1987-2003: a nationwide trend analysis.
Lundholm C; Forsgren C; Johansson AL; Cnattingius S; Altman D
Acta Obstet Gynecol Scand; 2009; 88(1):52-8. PubMed ID: 19140043
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the effect of levonorgestrel IUD with oral medroxyprogesterone acetate on abnormal uterine bleeding with simple endometrial hyperplasia and fertility preservation.
Karimi-Zarchi M; Dehghani-Firoozabadi R; Tabatabaie A; Dehghani-Firoozabadi Z; Teimoori S; Chiti Z; Miratashi-Yazdi A; Dehghani A
Clin Exp Obstet Gynecol; 2013; 40(3):421-4. PubMed ID: 24283179
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of hysteroscopic findings and histologic diagnoses in patients with abnormal uterine bleeding.
Lasmar RB; Dias R; Barrozo PR; Oliveira MA; Coutinho Eda S; da Rosa DB
Fertil Steril; 2008 Jun; 89(6):1803-7. PubMed ID: 17889860
[TBL] [Abstract][Full Text] [Related]
26. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
Chan SS; Tam WH; Yeo W; Yu MM; Ng DP; Wong AW; Kwan WH; Yuen PM
BJOG; 2007 Dec; 114(12):1510-5. PubMed ID: 17995495
[TBL] [Abstract][Full Text] [Related]
27. Validation of hysteroscopic view in cases of endometrial hyperplasia and cancer in patients with abnormal uterine bleeding.
Lasmar RB; Barrozo PR; de Oliveira MA; Coutinho ES; Dias R
J Minim Invasive Gynecol; 2006; 13(5):409-12. PubMed ID: 16962523
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes after intrauterine morcellation vs hysteroscopic resection of endometrial polyps.
AlHilli MM; Nixon KE; Hopkins MR; Weaver AL; Laughlin-Tommaso SK; Famuyide AO
J Minim Invasive Gynecol; 2013; 20(2):215-21. PubMed ID: 23295201
[TBL] [Abstract][Full Text] [Related]
29. A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents.
Paterson H; Ashton J; Harrison-Woolrych M
Contraception; 2009 Jun; 79(6):433-8. PubMed ID: 19442778
[TBL] [Abstract][Full Text] [Related]
30. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.
Ørbo A; Arnes M; Hancke C; Vereide AB; Pettersen I; Larsen K
Gynecol Oncol; 2008 Oct; 111(1):68-73. PubMed ID: 18684496
[TBL] [Abstract][Full Text] [Related]
31. Concomitant hysteroscopic endometrial ablation and Essure procedure: feasibility, efficacy and satisfaction.
Levy-Zauberman Y; Legendre G; Nazac A; Faivre E; Deffieux X; Fernandez H
Eur J Obstet Gynecol Reprod Biol; 2014 Jul; 178():51-5. PubMed ID: 24813100
[TBL] [Abstract][Full Text] [Related]
32. Efficiency and pregnancy outcome of serial intrauterine device-guided hysteroscopic adhesiolysis of intrauterine synechiae.
Pabuccu R; Onalan G; Kaya C; Selam B; Ceyhan T; Ornek T; Kuzudisli E
Fertil Steril; 2008 Nov; 90(5):1973-7. PubMed ID: 18774563
[TBL] [Abstract][Full Text] [Related]
33. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
[TBL] [Abstract][Full Text] [Related]
34. What's new in gynecologic endoscopy: endometrial ablation.
Serden SP
Semin Perioper Nurs; 1993 Jul; 2(3):166-71. PubMed ID: 8044167
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the levonorgestrel-releasing intrauterine system, hysterectomy, and endometrial ablation for heavy menstrual bleeding in a decision analysis model.
Louie M; Spencer J; Wheeler S; Ellis V; Toubia T; Schiff LD; Siedhoff MT; Moulder JK
Int J Gynaecol Obstet; 2017 Nov; 139(2):121-129. PubMed ID: 28796898
[TBL] [Abstract][Full Text] [Related]
36. A cost-utility analysis of hysterectomy, endometrial resection and ablation and medical therapy for menorrhagia.
You JH; Sahota DS; MoYuen P
Hum Reprod; 2006 Jul; 21(7):1878-83. PubMed ID: 16585125
[TBL] [Abstract][Full Text] [Related]
37. Changing hysterectomy technique from open abdominal to laparoscopic: new trend in Oslo, Norway.
Istre O; Langebrekke A; Qvigstad E
J Minim Invasive Gynecol; 2007; 14(1):74-7. PubMed ID: 17218234
[TBL] [Abstract][Full Text] [Related]
38. Intrauterine devices and intrauterine systems.
ESHRE Capri Workshop Group
Hum Reprod Update; 2008; 14(3):197-208. PubMed ID: 18400840
[TBL] [Abstract][Full Text] [Related]
39. [Does repeated endometrial destruction procedure decrease abnormal uterine bleeding, and does it reduce the number of hysterectomies in this indication?].
Levy-Zauberman Y; Fernandez H; Pourcelot AG; Legendre G
J Gynecol Obstet Biol Reprod (Paris); 2014 Jan; 43(1):35-9. PubMed ID: 24286929
[TBL] [Abstract][Full Text] [Related]
40. Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up.
Wildemeersch D; Janssens D; Pylyser K; De Wever N; Verbeeck G; Dhont M; Tjalma W
Maturitas; 2007 Jun; 57(2):210-3. PubMed ID: 17270370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
